A team of researchers from institutions in Italy and the U.S., in conjunction with several corporate entities, has found that adding a protein to lentiviral vectors can protect them from an immune system attack. In their paper published in the journal Science Translational Medicine, the group describes their work in finding new ways to treat hemophilia and how well their approach worked in monkeys.
* This article was originally published here
